Egle Therapeutics Secures €9.3 Million in State Funding to Advance Treg-Targeting Immunotherapies Egle Therapeutics, a clinical-stage biotechnology company specializing in the development of immunotherapies targeting regulatory T cells (Tregs), has…
Edifecs Expands Risk Adjustment Capabilities with Point of Care Suspects Solution Edifecs, Inc., a global leader in health information technology solutions, has announced the launch of Point of Care Suspects,…
OM1 Enters European Market to Enhance AI-Powered Real-World Evidence Solutions for Life Sciences OM1, a leader in real-world data (RWD) and AI-driven insights for the life sciences industry, has announced…
Pramana Partners with ARUP Laboratories to Digitize Pathology Slides and Develop AI Hematopathology Algorithms Pramana, Inc., an AI-driven health tech company focused on transforming the pathology industry, has teamed up…
Strive Health Expands Partnership with Zing Health for Value-Based Kidney Care Strive Health, a national leader in value-based kidney care, has expanded its partnership with Zing Health, a prominent Medicare…
Greenspace Health Secures Series B Investment from ABS Capital to Innovate Behavioral Health Greenspace Health, a leading provider of SaaS Measurement-Based Care (MBC) technology, has successfully secured a Series B…
LifeStance Names Dave Bourdon CEO, Ken Burdick Executive Chairman LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental health care,…
Philips and Ingeborg Initiatives Tackle Maternal Health Challenges in Arkansas via Philips Avent Pregnancy+ App Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has partnered with…
IHI Unveils New Human Factors Certification and Safer Together Program at Patient Safety Congress The 2025 IHI Patient Safety Congress officially launched today, gathering healthcare professionals, patient safety advocates, and…
GoodRx Report Highlights Gender Divide in Prescription Spending GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., has released a new report titled The Prescription Drug Gender…
First Real-World Study Shows GenAI-Powered Mental Health Treatment Outperforms Standard Care The first real-world study on the use of Generative Artificial Intelligence (GenAI) in mental health treatment across multiple clinical…
VTAMA® Phase 3 Data Shows Sustained Low Atopic Dermatitis Activity After Treatment-Free Interval Organon (NYSE: OGN), a global healthcare company specializing in women’s health, announced the results of a new…